-
Apply for the Global Oncology Young Investigator Award (GO YIA)
The Global Oncology Young Investigator Award (GO YIA) provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation of researchers to address global health needs. Global oncology is a general term that refers to the application of the concepts of global health to cancer, and implies an approach to the practice of oncology that acknowledges the reality of limited resources in most parts of the world.
The Global Oncology Young Investigator Award is intended to support: (more…)
-
ASCO Career Development Award (CDA)
The Career Development Award (CDA) provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. (more…)
-
International Innovation Grant (IIG) Letters of Intent (LOI) are due July 31, 2020
The International Innovation Grant (IIG) provides research funding in support of novel and innovative projects that can have a significant impact on cancer control in low- and middle-income countries (LMCs). It is intended to support proposals that have the potential to reduce the cancer burden in local communities, while also being potentially transferable to other low- or middle-income settings.
Letters of Intent (LOI) are due July 31, 2020. Only approved LOIs will be invited for full application. Submission of full application is due on October 20, 2020.
Click here for details on available funding, eligibility criteria and application instructions on the ASCO website.
-
ASHG Announces Dr Charles Rotimi as 2021 President-elect and Member, Board of Directors
We are highly pleased to announce that a Nigerian-born genetic epidemiologist, Dr. Charles Rotimi, made a mark again as the new Presi
dent-elect of the American Society of Human Genetics (ASHG).
This was recently announced in the press release of the ASHG. Read the press release here
Dr Charles Rotimi is a high-achieving researcher with numerous contributions to research in Africa. Read more about him here and here.
-
IACR Newsflash: Results Overview of the Cancer Registries and COVID-19 Survey
In mid-May, the COVID-19 and Cancer Task Force, through IACR and GICR, reached out to cancer registries with a survey to assess the impact of the COVID-19 pandemic on cancer registration. A total of 218 cancer registries from 90 countries participated in this survey. With sincere thanks to each registry for taking the time to provide feedback on how the COVID-19 pandemic has impacted their respective cancer registry operations, we are pleased to share an overview of the survey results:
-
Updates on the 2020 Scientific Conference, IACR Noumea
The IACR Board has recently released an official statement explaining the decision to cancel the 2020 IACR Scientific Conference, scheduled to hold in Noumea, New Caledonia later this year.
Below are details of the announcement:
-
Update on 8th Annual Symposium on Global Cancer Research
We hope this message finds you and your communities safe during the on-going COVID-19 pandemic. As you know, due to the pandemic, the 8th Annual Symposium on Global Cancer Research, originally scheduled for April 17th in Washington, DC had to be cancelled. We are pleased to inform you of the plans to share scientific content from the Symposium in partnership with the Consortium of Universities for Global Health as part of their global health webinar series. The upcoming webinars are:
-
Official launch “World Cancer Report: Cancer Research for Cancer Prevention”
The publication of World Cancer Report: Cancer Research for Cancer Prevention, was launched recently, on the occasion of the 20th anniversary of World Cancer Day. (more…)